Elevated Prothrombin Time and International Normalized Ratio Caused by Drug-Drug Interactions Between Warfarin and Pranlukast

Am J Ther. 2023 May 1;30(3):e302-e303. doi: 10.1097/MJT.0000000000001394.

Authors

Erika Tamai^{1

2}, Takeo Yasu^{1

2

3}, Eri Hikita¹, Mikio Shirota¹

Affiliations

¹ Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
² Tokyo metropolitan Tama Kodaira Public Health Center, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Tokyo, Japan.
³ Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Tokyo, Japan.

PMID: 34050048
DOI: 10.1097/MJT.0000000000001394

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants* / adverse effects
Drug Interactions
Humans
International Normalized Ratio
Prothrombin Time
Warfarin* / adverse effects

Substances

Warfarin
pranlukast
Anticoagulants